Korean J Gastroenterol.  2006 May;47(5):350-356.

Cyclo-oxygenase-2 and p53 Immunoreactivity in Superficial Early Colorectal Carcinoma

Affiliations
  • 1Departments of Internal Medicine, Inje University College of Medicine, Seoul, Korea.
  • 2Departments of Pathology, Inje University College of Medicine, Seoul, Korea. yousunk69@korea.com

Abstract

BACKGROUND/AIMS
De novo colorectal carcinoma shows more aggressive behavior including submucosal invasiveness. Both p53 and cyclo-oxygenase-2 (COX-2) have been shown to be involved in colon carcinogenesis, progression from adenoma to carcinoma, and submucosal invasion by tumor. We performed this study to evaluate the expression of p53 and COX-2 protein in de novo carcinoma, compared with ex-adenoma carcinoma. METHODS: Twenty three flat adenomas, 19 ex-adenoma carcinomas, 6 de novo carcinomas were included in this study. The expression of p53, COX-2 and Ki-67 were examined immunohistochemically. RESULTS: Both ex- adenoma carcinomas and de novo carcinomas showed similar size and shape. Positive staining for p53 was detected in 3 of 23 (13%) flat adenomas, in 11 of 19 (57.8%) ex-adenoma carcinomas (p<0.05), and in 1 of 6 (16.6%) de novo carcinomas. Increased numbers of COX-2 positive tumor cells were observed in 1 of 23 (4.3%) flat adenomas, in 2 of 19 (10.5%) ex-adenoma carcinomas, and in 3 of 6 (50%) de novo carcinomas. COX-2 positive expression showed increased tendency in de novo carcinoma (p=0.073). There was no correlation between COX-2, p53, and Ki-67 expression. CONCLUSION: De novo carcinoma shows increased tendency of COX-2 expression, but decreased p53 expression when compared to ex-adenoma carcinoma. These immunohistochemical findings are in accordance with the fact that de novo carcinoma has no preceding adenoma, with more frequent submucosal invasion despite the small lesion size.

Keyword

Colorectal Neoplasm; p53; Cyclo-oxygenase-2

MeSH Terms

Adenoma/chemistry/pathology
Carcinoma/chemistry/pathology
Colorectal Neoplasms/chemistry/*pathology
Cyclooxygenase 2/*analysis
Female
Humans
Immunohistochemistry
Ki-67 Antigen/analysis
Male
Middle Aged
Tumor Markers, Biological/analysis
Tumor Suppressor Protein p53/*analysis
Full Text Links
  • KJG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr